Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07425496 · ClinicalTrials.gov registry record
To Study Ocular Outflow Dynamics of the Eye Using Intraoperative Tonographic Biometry and Assess Its Predictive Value in Improving Postoperative Outcomes.
A clinical trial of Glaucoma and Cataract, sponsored by The New York Eye & Ear Infirmary.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT07425496: Recruiting study of Glaucoma and Cataract, sponsored by The New York Eye & Ear Infirmary.
NCT07425496 is a study of Glaucoma and Cataract that is actively recruiting participants, run by The New York Eye & Ear Infirmary. The registered enrollment target is 150 participants, below the 909-participant average among 92 other Glaucoma trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07425496, a study of Glaucoma and Cataract, is actively recruiting participants, sponsored by The New York Eye & Ear Infirmary.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate ocular outflow dynamics of the eye using intraoperative tonographic biometry and assess its predictive value in improving postoperative outcomes.
Primary Outcome
Measure the intra ocular pressure measurement during surgery to better inform surgeons of post-operative management and outcomes.
Interventions
- DIAGNOSTIC_TEST disposable Deltran I pressure sensor
Study Locations (1)
New York
- New York Eye and Ear Infirmary of Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-08-26 |
| Est. Completion | 2028-12 |
What NCT07425496 shows while recruiting
NCT07425496 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 909-participant average among 92 other Glaucoma trials with a reported enrollment target (83% lower).
The record links to 2 conditions, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which disposable Deltran I pressure sensor is the first listed.
NCT07425496 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07425496 about?
NCT07425496 is a clinical study titled "To Study Ocular Outflow Dynamics of the Eye Using Intraoperative Tonographic Biometry and Assess Its Predictive Value in Improving Postoperative Outcomes.". The objective of this study is to evaluate ocular outflow dynamics of the eye using intraoperative tonographic biometry and assess its predictive value in improving postoperative outcomes.
What is the current status of trial NCT07425496?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2025-08-26. Estimated completion is 2028-12.
What conditions does trial NCT07425496 study?
This clinical trial studies the following conditions: Glaucoma, Cataract.
What interventions are being tested in trial NCT07425496?
The interventions under investigation include: disposable Deltran I pressure sensor (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07425496?
This trial is sponsored by The New York Eye & Ear Infirmary, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07425496 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07425496's enrollment target sits among peer trials
150 33rd of 92 higher than 59 of 92 other Glaucoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Glaucoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Functional and Structural Imaging for Glaucoma
RECRUITING
-
Topical Insulin for Glaucoma
RECRUITING · Phase 1
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension
RECRUITING · Phase 2
-
Eye Pressure Lowering Surgery
RECRUITING
-
Tolerability of an Anesthesia-free Tonometer Tip
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI